This web page was created programmatically, to learn the article in its unique location you may go to the hyperlink bellow:
https://www.news-medical.net/news/20250917/University-of-Maine-team-develops-sustainable-method-to-cut-drug-production-costs.aspx
and if you wish to take away this text from our website please contact us
One of the principle components driving costs in prescribed drugs, resembling cholesterol-lowering medication and antibiotics, is the price of manufacturing and supplies. Researchers on the University of Maine Forest Bioproducts Research Institute (FBRI) have found a sustainable methodology to supply the important thing ingredient in a broad vary of prescribed drugs, which might assist handle excessive prescription drug prices within the U.S.
Among among the costliest drugs are people who require a chiral heart – a property during which a molecule can’t be superimposed with its mirror picture, like proper and left fingers. Chirality can direct a drug’s organic results together with efficacy, uncomfortable side effects and metabolization. The worth of chiral medication is significantly contributed to the constructing blocks used throughout synthesis, that are expensive to supply on account of complicated response and purification pathways.
In a brand new examine lately printed in Chem, FBRI researchers discover a brand new, cost-reducing pathway to supply one in all these essential constructing blocks, (S)-3-hydroxy-γ-butyrolactone (HBL), from glucose at excessive concentrations and yields.
According to researchers, HBL is a chiral species used for the synthesis of an array of essential medication resembling statins, antibiotics and HIV inhibitors. Because glucose might be derived from any lignocellulosic feedstock – resembling wooden chips, sawdust, tree branches or different woody biomass – this course of opens a brand new door for the sustainable manufacturing of HBL. This method might additionally doubtlessly be used to supply different forms of necessary client merchandise.
If we use different kinds of wooden sugars, like xylose that’s an unneeded byproduct from making pulp and paper, we anticipate that we might produce new chemical compounds and constructing blocks, like inexperienced cleansing merchandise or new renewable, recyclable plastics.”
Thomas Schwartz, affiliate director of FBRI and affiliate professor within the Maine College of Engineering and Computing who was a lead creator for the paper
In addition to its use as a chiral species, HBL has been recognized as a extremely beneficial precursor to quite a lot of chemical compounds and plastics by the U.S. Department of Energy. Previous makes an attempt to supply HBL sustainably achieved solely restricted success on account of issues of safety, ineffectiveness or a scarcity of cost-efficiency.
“The competing processes either lead to low yields, use hazardous starting materials or are just generally costly because of the chosen production scheme and low output,” stated Schwartz. “The commercial process is expensive because you have to add the chiral center to the molecule, which doesn’t occur naturally with most petrochemicals.”
Not solely does this new method lead to considerably decreased greenhouse fuel emissions, however the manufacturing prices are additionally decreased by greater than 60% in comparison with present strategies that use petroleum-derived feedstocks. The course of can even yield different commercially necessary chemical compounds, resembling glycolic acid (GA), which presents extra financial alternatives.
The analysis included work from college students within the UMaine Catalysis Group led by Schwartz and was performed in collaboration with the U.S. Department of Agriculture (USDA) Forest Products Laboratory and the University of Wisconsin–Madison. Funding for the challenge was offered by the USDA, U.S. Forest Service and the National Science Foundation.
Source:
Journal reference:
Waters, J. O. P., et al. (2025). Production of biorenewable, enantiopure (S)-3-hydroxy-γ-butyrolactone for pharmaceutical purposes. Chem. doi.org/10.1016/j.chempr.2025.102665
This web page was created programmatically, to learn the article in its unique location you may go to the hyperlink bellow:
https://www.news-medical.net/news/20250917/University-of-Maine-team-develops-sustainable-method-to-cut-drug-production-costs.aspx
and if you wish to take away this text from our website please contact us
